Table 1.

Studies on acarbose to inhibit amylase in type 2 diabetes mellitus patients

Ref.	Population	Methods	Outcomes
Chen et al[8], 2023	17 Chinese T2DM patients, enrolled for 8 wk	Acarbose (100 mg; 3 times/d) + DF-rich diet; control group: Standard diet	Intervention resulted in decreased HbA1c, fasting glucose, and insulin sensitivity. No significant changes in the control group
Zhao et al[9], 2018	43 Chinese T2DM patients, enrolled for 11 wk	Acarbose (100 mg; 3 times/d) + DF-rich diet; control group: Standard diet	Intervention group showed sustained better glycemic control (HbA1c < 7%) for 89% of participants compared to the control. No significant differences in fasting glucose levels

T2DM: Type 2 diabetes mellitus; DF: Dietary fiber; Hb1Ac: Glycated hemoglobin.